Dendreon (Nasdaq: DNDN) moved higher intra-day following news that the FDA approved the remainder of its New Jersey manufacturing facility ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE